
Johns and Cunningham's The Physics of Radiology
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
More details
Other editions
Additional editions
Content
- Intro
- THE PHYSICS OF RADIOLOGY
- PREFACE
- ACKNOWLEDGMENTS
- CONTENTS
- Chapter 1 BASIC CONCEPTS
- Chapter 2 THE FUNDAMENTALS OF NUCLEAR PHYSICS
- Chapter 3 INTERACTION OF IONISING RADIATION WITH MATTER
- Chapter 4 THE PRODUCTION AND PROPERTIES OF KILOVOLTAGE X-RAY BEAMS
- Chapter 5 HIGH-ENERGY MACHINES
- Chapter 6 RADIOISOTOPES FOR MEDICAL IMAGING & RADIOTHERAPY
- Chapter 7 RADIATION DOSIMETRY: THE MEASUREMENT OF IONIZING RADIATION
- Chapter 8 MEASUREMENT OF RADIATION: INSTRUMENTATION
- Chapter 9 BASIC RADIOBIOLOGY
- Chapter 10 CLINICAL RADIOBIOLOGY
- Chapter 11 DIAGNOSTIC RADIOLOGY
- Chapter 12 DIAGNOSTIC NUCLEAR MEDICINE
- Chapter 13 CHARACTERISTICS OF RADIOTHERAPY PHOTON BEAMS
- Chapter 14 THE INTERACTION OF PHOTON BEAMS WITH A SCATTERING MEDIUM
- Chapter 15 EXTERNAL PHOTON BEAM DOSE CALCULATION
- Chapter 16 PHOTON BEAM TREATMENT: DOSE PRESCRIPTION AND REPORTING
- Chapter 17 PHOTON BEAM TREATMENT: PLANNING AND DELIVERY
- Chapter 18 EXTERNAL ELECTRON BEAMS
- Chapter 19 RADIOTHERAPY WITH NEUTRONS, PROTONS AND HEAVY IONS
- Chapter 20 BRACHYTHERAPY
- Chapter 21 MOLECULAR RADIOTHERAPY
- Chapter 22 RADIATION PROTECTION
- THE PHYSICS OF RADIOLOGY
- Chapter 1 BASIC CONCEPTS
- 1.1 INTRODUCTION
- 1.2 QUANTITIES AND UNITS
- 1.2.1 Mechanical Quantities and Units
- 1.2.2 Electrical Quantities and Units
- 1.2.3 Radiation Quantities and Units
- 1.2.4 Prefixes
- 1.3 ATOMS, NUCLEI AND ELEMENTARY PARTICLES
- 1.4 ELECTRONIC STRUCTURE
- 1.5 ATOMIC AND NUCLEAR ENERGY LEVELS
- 1.5.1 Atomic Energy Levels
- 1.5.2 Nuclear Energy Levels
- 1.6 ELECTROMAGNETIC RADIATION AND THE ELECTROMAGNETIC SPECTRUM
- 1.6.1 The Quantum Nature of Radiation
- 1.6.2 The EM Spectrum
- 1.7 RADIATION OF ENERGY FROM ATOMIC ELECTRONS
- 1.8 MASS, ENERGY AND VELOCITY - SPECIAL RELATIVITY
- 1.8.1 Mass and Energy
- 1.8.2 Mass and Velocity
- 1.9 THE EXPONENTIAL FUNCTION AND ITS IMPORTANCE IN RADIATION PHYSICS
- 1.9.1 Growth of Cells in a Cell Colony
- 1.9.2 Exponential Killing of Cells
- 1.9.3 Decay of Radioactive Isotopes
- 1.9.4 Exponential Attenuation
- 1.9.5 Summary of Exponential Behaviour
- PROBLEMS
- REFERENCE
- Chapter 2 THE FUNDAMENTALS OF NUCLEAR PHYSICS
- 2.1 NATURAL RADIOACTIVITY
- 2.2 ARTIFICIAL RADIOACTIVITY
- 2.3 ACTIVITY
- 2.3.1 Exponential Decay of Some Commonly Used Isotopes
- 2.4 CHARTS OF ISOTOPES
- 2.5 ALPHA DECAY
- 2.6 BETA DECAY
- 2.7 BETA MINUS (b-) DECAY
- 2.8 BETA PLUS (b+) DECAY
- 2.9 ELECTRON CAPTURE
- 2.10 GAMMA DECAY
- 2.11 INTERNAL CONVERSION
- 2.12 AUGER ELECTRONS
- 2.13 ISOMERIC TRANSITIONS
- 2.14 ENERGY ABSORPTION FROM RADIOACTIVE ISOTOPES
- 2.15 DECAY SERIES
- 2.16 GROWTH OF RADIOACTIVE DAUGHTER
- 2.17 NUCLEAR FISSION
- 2.18 NUCLEAR FUSION
- 2.19 NUCLEAR REACTIONS
- 2.20 INTERACTION CROSS-SECTIONS
- 2.21 ACTIVATION
- 2.22 ACTIVITY PRODUCED BY NEUTRON IRRADIATION
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 3 INTERACTION OF IONIZING RADIATION WITH MATTER
- 3.1 ABSORPTION OF ENERGY
- 3.2 ATTENUATION, LINEAR ATTENUATION COEFFICIENT AND HALF-VALUE LAYER
- 3.2.1 Half-Value Layer
- 3.2.2 Narrow and Broad Beams
- 3.3 MASS, ELECTRONIC AND ATOMIC ATTENUATION COEFFICIENTS
- 3.4 ENERGY TRANSFER AND ABSORPTION
- 3.4.1 Energy Transfer Coefficient
- 3.4.2 Energy Absorption Coefficient
- 3.5 PHOTON INTERACTION PROCESSES
- 3.5.1 Coherent (Classical) Scattering
- 3.5.2 Photoelectric Absorption
- Variation of the Photoelectric Process with Photon Energy
- Variation of the Photoelectric Process with Atomic Number
- Photoelectric Transfer and Absorption Coefficients in Low Z Materials
- Photoelectric Transfer Effect in Higher Z Materials
- Summary of Photoelectric Interaction Process
- 3.5.3 Compton Interaction Process
- Compton Cross Sections
- Mean Energy Transferred in the Compton Process
- Compton Energy Transfer Coefficient
- Compton Coefficients Including the Effects of Binding Energy
- Summary of the Compton Process
- 3.5.4 Pair Production Process
- Fate of the Positron
- Triplet Production
- Variation of Pair Production with Energy and Atomic Number
- Energy Transfer and Energy Transfer Coefficients for Pair Production
- Summary for Pair (and Triplet) Production
- 3.5.5 Total Attenuation, Energy Transfer and Absorption Coefficients
- Total Attenuation Coefficient
- Total Coefficient for Compounds or Mixtures
- Total Energy Transfer and Absorption Coefficients
- 3.5.6 The Relative Importance of the Four Interaction Processes
- Absorption of Photon Radiation by Biological Tissues
- 3.5.7 Conclusion
- 3.6 COHERENT (THOMSON AND RAYLEIGH) SCATTERING
- 3.6.1 Thomson Scattering
- 3.6.2 Rayleigh Scattering
- 3.7 COMPTON SCATTERING
- 3.7.1 Prediction of Energy-Angle Relationships in Compton Interactions
- 3.7.2 Probability of Compton Collision (Klein-Nishina Coefficients)
- Total Coefficient for Compton Process
- Scatter Coefficient for Compton Process
- 3.7.3 Kinetic Energy Transfer via Compton Process
- Mean Energy of Compton Recoil Electrons
- Energy Distribution of Compton Electrons
- 3.7.4 Effects of Binding Energy on Compton Scattering
- 3.8 PAIR AND TRIPLET PRODUCTION
- 3.8.1 Energy Distribution of Electrons and PositronsProduced in Pair Production Process
- 3.8.2 Energy Transfer in Pair Production
- 3.9 INTERACTIONS OF HEAVY CHARGED PARTICLES WITH MATTER
- 3.9.1 Ionization Stopping Power
- 3.9.2 Bragg Curves for Heavy Particles
- 3.10 INTERACTION OF ELECTRONS WITH MATTER
- 3.10.1 Ionization Stopping Power
- 3.10.2 Radiative Stopping Power
- 3.10.3 Range of Electrons and Bremsstrahlung Yield
- Range of Electrons
- Bremsstrahlung Yield
- 3.10.4 Electron Scattering
- Electron-Nucleus Scattering
- Electron-Electron Scattering
- Multiple Scattering - the Fermi-Eyges Approach
- Mass Angular Scattering Power
- 3.11 ELECTRON SPECTRA PRODUCED BY PHOTON INTERACTIONS IN A MEDIUM
- 3.11.1 Energy Distribution of Electrons Generated by 10 MeV Photons
- Mean Energy Transferred
- Energy Loss to Bremsstrahlung
- Energy Absorption Coefficient
- 3.11.2 Energy Spectrum of Electrons Seen in the Medium
- Electron Spectra Resulting from Monoenergetic Electrons
- Electron Spectra Resulting from a Distribution of Initial Electron Energies
- 3.12 MEAN ELECTRON STOPPING POWER
- 3.12.1 Mean Stopping Power for Monoenergetic Electrons Set in Motion in Medium
- 3.12.2 Mean Stopping Powers for Polyenergetic Electrons Setin Motion in Medium by Monoenergetic Photons
- 3.12.3 Mean Stopping Powers for Electrons Set in Motionby a Spectrum of Photon Energies
- 3.12.4 Restricted Stopping Power and Linear Energy Transfer
- PROBLEMS
- REFERENCES
- Chapter 4 THE PRODUCTION AND PROPERTIES OF KILOVOLTAGE X-RAY BEAMS
- 4.1 PRODUCTION OF X-RAYS
- 4.1.1 Basic Electron Interactions in an X-ray Target
- 4.1.2 Characteristic Radiation
- 4.1.3 Bremsstrahlung
- Thin Target Radiation
- Thick Target Radiation
- 4.1.4 Angular Distribution of X-rays
- Thin Targets
- Thick Targets
- 4.1.5 Measured X-Ray Spectra
- 4.2 X-RAY QUALITY
- 4.2.1 Measurement of HVL
- 4.2.2 Effects of Scatter on HVL Measurements
- 4.2.3 Effects of Detector on HVL Measurements
- 4.2.4 Filters for Radiation Therapy and Diagnostic Radiology
- Radiation Therapy Filters
- Diagnostic Radiology Filters
- 4.2.5 Equivalent Photon Energy
- 4.2.6 Further Notes on X-ray Spectra
- Measurement of X-ray Spectra
- Effects of Filters on X-ray Spectra
- Effects of Special High-Z Filters
- Types of Spectral Distribution
- Spectral Distribution of Scattered Radiation
- 4.3 PRINCIPLES OF X-RAY TECHNOLOGY
- 4.3.1 The X-ray Tube and the Simplified Circuit
- 4.3.2 Self-Rectified X-ray Circuits
- Alternating Currents and Voltages
- Current Pulse in an X-ray Circuit
- 4.3.3 Rectification
- Half-Wave and Full-Wave Rectification
- 4.3.4 Three-Phase Units
- Secondaries Connected in a Delta Configuration
- Three-Phase 12-Rectifier System
- 4.3.5 Anode and Cathode Structures
- Diagnostic X-ray Tubes
- X-ray Tubes for Radiotherapy
- 4.3.6 Ratings of Diagnostic Tubes
- Focal Spot Loading
- Anode Cooling
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 5 HIGH-ENERGY MACHINES
- 5.1 INTRODUCTION
- 5.2 CONSIDERATIONS IN THE DESIGN OF HIGH-ENERGY BEAMS
- 5.3 BETATRONS
- 5.4 THE LINEAR ACCELERATOR (LINAC)
- 5.5 MEDICAL LINACS
- 5.5.1 Medical Linear Accelerators: Waveguideand Treatment Head (Additional Notes)
- 5.5.2 FFF Linacs
- 5.6 ISOTOPE MACHINES
- 5.7 COBALT 60 UNITS
- 5.8 SPECIAL MEDICAL ACCELERATORS
- 5.8.1 Tomotherapy
- 5.8.2 Gamma-knife
- 5.8.3 CyberKnife
- 5.8.4 MRI Linac
- 5.9 PARTICLES FOR RADIOTHERAPY
- 5.9.1 Medical Particle Accelerators
- 5.9.1.1 Beam Shaping
- 5.9.1.2 Other Charged Particles
- 5.9.2 Neutron Accelerators
- 5.9.3 Fast Neutron Therapy
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 6 RADIOISOTOPES FOR MEDICAL IMAGING & RADIOTHERAPY
- 6.1 INTRODUCTION
- 6.2 STRUCTURE OF MATTER FROM AN ISOTOPIC PERSPECTIVE
- 6.3 "NEUTRON-RICH" & "PROTON-RICH" ISOTOPES
- 6.4 Q-VALUE, THRESHOLD ENERGY & STARTING ENERGY
- Endoergic reactions.
- 6.4.1 Coulomb Barrier & Starting Energy
- Exoergic reactions.
- 6.5 NOMENCLATURE
- 6.6 MICROSCOPIC NUCLEAR CROSS SECTION & EXCITATION FUNCTION
- 6.7 ION BEAM STOPPING POWER & RANGE
- 6.7.1 Beam Energy, Range & Straggling of Ion Beams
- Beam Energy and Energy Straggling
- Beam Range and Range Straggling
- 6.8 RADIOISOTOPIC YIELD
- 6.8.1 Saturation Activity and Yield
- 6.8.2 Productions Well Below the Saturation Activity
- 6.8.3 Thick Targets
- 6.9 ACCELERATORS FOR BIOMEDICAL RADIOISOTOPES PRODUCTION
- Penning Ion Source
- 6.9.1 Electrostatic (DC) Accelerators
- 6.9.2 Radiofrequency (RF) Accelerators
- Linacs.
- Betatrons
- 6.9.3 The Isochronous Compact Negative-Ion "Medical" Cyclotron
- Technology of a Compact Cyclotron for Radioisotopes Production
- Components of a cyclotron.
- Operation of a cyclotron.
- Relativistic mass.
- "Wandering orbit".
- Optimization of Cyclotrons for Radioisotopes Production
- Design features of routine production systems.
- 6.9.4 Targetry for the Production of Radioisotopes
- Major components of a targetry system.
- Solid Targetry
- Gas Targetry
- Production of 18F using gas targetry.
- Liquid Targetry
- Production of 18F using liquid targetry (example).
- 6.9.5 Measurement of the Beam Energy
- Direct Methods
- Time-of-flight methods.
- Magnetic analyser methods.
- Indirect Methods
- Monitor Reactions
- Beam current known.
- Beam current unknown
- Activity of only one monitor isotope required
- 6.9.6 Measurement of Beam Current
- Direct Methods
- Secondary electrons emission (SEE)
- Indirect Methods
- 6.9.7 Determining an Excitation Function
- Measuring the excitation function
- 6.9.8 Theoretical Calculations of Excitation Functions
- Direct and Compound Reactions
- Pre-equilibrium Reactions
- Emission spectra.
- Model Descriptions of Nuclear Reactions
- Optical model and optical potential
- Hauser-Feshbach (HF) model
- Exciton model
- Computational Algorithms
- ALICE-IPPE
- EMPIRE
- TALYS
- Comparison of Algorithms
- 6.10 NUCLEAR REACTOR PRODUCTION OF MEDICAL RADIOISOTOPES
- Nuclear fission
- Barrier energy (Eb)
- Excitation energy (Q )
- 6.10.1 Radioisotopes Production Using Uranium Fission
- Macroscopic reaction cross section.
- Fission product activity
- Energy release from fission
- 6.10.2 Operations of a Nuclear Reactor
- Moderating material and chain reaction
- Movable control elements ("rods")
- Neutron reflector
- Coolant.
- The pressure vessel
- The containment structure
- Effective Reactivity and Critical Mass
- Specialized Nuclear Reactors for High Neutron Fluxes
- Excess reactivity
- Target location
- 6.10.3 Production of Radioisotopes from Fission Products
- Example: Production of 99Mo from 235U Fission
- 6.10.4 Production of Radioisotopes from Neutron Activation of a Target
- Example: Production of 99Mo by Neutron Activation
- 6.11 RADIOACTIVE WASTE FROM ACCELERATORS & REACTORS
- 6.11.1 Radioactive Waste from Particle Accelerators
- Activation of bunker walls
- Activation of accelerator structural components.
- Activation of the bunker air and its expulsion into the environment
- 6.11.2 Radioactive Waste from Research Nuclear Reactors
- 6.12 NUCLEAR MEDICINE WITHOUT NUCLEAR REACTORS?
- 6.12.1 Comparison of Accelerator- vs. Reactor-based Productions
- Financial, environmental and social "footprints" of the installation.
- Legacy of enriched uranium fuel
- Production and storage of long lived intermediate level radioactive waste
- Separation of radionuclides from target material.
- Decommissioning of spent facilities
- 6.12.2 Which "Reactor" Radioisotopes Could be Produced in an Accelerator?
- Production of "Reactor" Isotopes by Neutron Spallation
- Production of "Reactor" Isotopes by Cyclotron
- 6.12.3 Accelerator-based Production of 99mTc: A Possible Paradigm Shift?
- 6.13 RADIOISOTOPIC GENERATORS
- 6.13.1 The 99Mo/99mTc Generator
- 6.13.2 Secular & Transient Equilibria in Radioisotopic Generators
- Secular Equilibrium
- Transient Equilibrium
- Other Aspects: Multiple Decay Chains and In Vivo Generators
- In vivo generator
- 6.14 ADVANCED TECHNOLOGIES FOR RADIOISOTOPES PRODUCTION
- 6.14.1 The Future of Cyclotrons
- 6.14.2 Particle Acceleration using Laser-generated EM Fields
- Application to Protons
- 6.15 RADIONUCLIDES FOR RADIOPHARMACEUTICALS SYNTHESES
- 6.15.1 The Concepts of Radiopharmaceutical & Radiotracer
- Investigating the efficacy and safety of a radiopharmaceutical
- Action of a diagnostic radiopharmaceutical (radiotracer): (radio)pharmacokinetics
- Action of a therapeutic radiopharmaceutical: (radio)pharmacodynamics
- 6.15.2 Specific Activity
- Specific activity: general definition
- Carrier-free specific activity (Scf)
- No-carrier-added (NCA) specific activity (Snca)
- Carrier-added specific activity (Sca).
- Effective specific activity (Seff)
- 6.15.3 Common Diagnostic Radioisotopes in Nuclear Medicine
- 6.15.4 Common Therapy Radioisotopes in Nuclear Medicine
- 6.15.5 Production of Emerging Targeting-therapy Isotopes
- Copper-67
- Scandiun-47.
- Astatine-211
- Actinium-225 and bismuth-213
- 6.16 DESIGN OF A "FIT-FOR-PURPOSE" RADIOPHARMACEUTICAL
- 6.16.1 Definition of a Radiopharmaceutical
- 6.16.2 Target-seeking Mechanisms of Radiopharmaceuticals
- Structural Levels of Tumor Target Recognition
- Targeting gross anatomic features of tumor
- Targeting tumor microvasculature: EPR effect
- Targeting biomolecular structures with "free" radioisotopes
- Targeting biomolecular structures with radiolabelled complexes
- Targeting of signature molecular targets on the cell surface
- 6.16.3 Optimal Choice of Radioisotope for Constructing a Radiopharmaceutical
- Half-life
- Accessibility.
- Specific activity
- Conjugation chemistry
- Suitable ionizing radiation emission
- Negligible unwanted radiations
- 6.16.4 Properties of the Ideal Radiopharmaceutical
- Efficient radiolabelling
- Labelling specificity
- Protection of binding affinity
- Stability in vitro and in vivo
- Target specificity
- Specific activity
- Routes and rapidity of accretion and excretion
- 6.16.5 Pharmacokinetics of Radiolabelled Antibodies & their Constructs
- Antibody structure
- Antibody pharmacokinetics
- Minibody pharmacokinetics
- Diabody pharmacokinetics
- 6.16.6 Mapping or Modifying Cellular Processes using Radiopharmaceuticals
- Ligands (First Messengers)
- Ligands.
- Lipophilic (freely diffusing) ligands
- Water-soluble (lipophobic) ligands
- Extracellular-matrix associated ligands
- Membrane-bound ligands
- Cell-signalling Receptors, Transporter Proteins and Ion Channels
- Cell-signalling receptors
- Transporter proteins and ion channels
- Second Messengers
- 6.17 SYNTHESIS & QA/QC OF A RADIOPHARMACEUTICAL
- 6.17.1 Production of [18F ]FDG as an Archetypal Radiopharmaceutical
- 6.17.2 QA Programme & QC Tests for [18F ]FDG: Radionuclidic Purity
- Quality assurance
- Quality control
- Experimental Photopeak Spectrum from Positron Annihilation
- Full energy peak (FEP)
- Compton edge
- Compton backscatter peak
- Compton continuum
- Range of Compton events
- Spectral features of multiple FEPs
- Germanium characteristic escape X-rays
- Bremsstrahlung
- Characteristic X-rays from lead shielding
- Features above the FEP
- Contaminating Radionuclides in Radioisotope Production
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 7 RADIATION DOSIMETRY: THE MEASUREMENT OF IONIZING RADIATION
- 7.1 THE DESCRIPTION OF A RADIATION BEAM
- 7.2 QUANTITIES DEFINED IN RADIATION MEASUREMENT:KERMA, ABSORBED DOSE, TERMA, AND EXPOSURE
- 7.2.1 Kerma
- 7.2.2 Absorbed Dose
- 7.2.3 Terma
- 7.2.4 Exposure
- 7.3 ELECTRONIC EQUILIBRIUM
- 7.4 THE BRAGG-GRAY CAVITY
- 7.4.1 Dose to a Small Gas-filled Cavity
- 7.4.2 Dose to the Cavity Wall
- Effects of Restricted Stopping Power on Mass Stopping Power Ratios
- Conclusion
- Spencer-Attix Cavity Theory
- 7.5 MEASUREMENT OF ABSORBED DOSE USING AN ABSOLUTE ION CHAMBER
- 7.5.1 Perturbation Correction Factors
- 7.5.2 Temperature and Pressure Correction Factors
- 7.6 ION CHAMBERS
- 7.6.1 Standard Air Chamber
- 7.6.2 Practical Ion Chambers
- The Effects of Wall Thickness on Ion Chamber Response
- 7.6.3 Effective Atomic Number
- 7.7 MEASUREMENTS OF ABSORBED DOSE USING AN IONIZATION CHAMBER
- 7.7.1 Absorbed Dose Measurement Using an Exposure Calibration Factor, Nx
- 7.7.2 Absorbed Dose Measurement Using an Absorbed Dose Calibration Factor, ND
- 7.7.3 Absorbed Dose Measurement above 3 MeV
- 7.7.4 Absorbed Dose Measurement with Electron Beams
- Electron Absorbed Doses for Thimble Chambers with Exposure Calibration Factors
- 7.7.5 Calibration Protocols at Radiation Metrology Laboratories
- 7.8 CALIBRATION PROTOCOLS
- 7.8.1 IAEA Protocol
- 7.8.2 IPEM (IPSM) Protocol
- 7.8.3 AAPM Protocol (TG-51)
- 7.8.4 Other Protocols
- 7.8.5 Kilovoltage Calibration Protocols
- Absolute dosimetry of very low-energy X-rays (IPEMB only)
- Absolute Dosimetry of Low-Energy X-rays
- Absolute Dosimetry of Medium Energy X-rays
- 7.8.6 Electron Calibration Protocols
- 7.9 ABSORBED DOSE AT INTERFACES BETWEEN DIFFERENT MATERIALS
- 7.9.1 Kilovoltage Energies
- 7.9.2 Megavoltage Energies
- 7.10 THEORETICAL DOSIMETRY (MONTE CARLO CALCULATIONS)
- 7.10.1 Boltzmann Radiation Transport Equation
- 7.10.2 The Monte Carlo Procedure
- Variance Reduction
- The Random Walk
- 7.10.3 Monte Carlo Codes in Radiotherapy
- EGSnrc Monte Carlo code
- BEAMnrc user code
- DOSXYZnrc user code
- PROBLEMS
- REFERENCES
- Chapter 8 MEASUREMENT OF RADIATION: INSTRUMENTATION
- 8.1 INTRODUCTION
- 8.2 SATURATION IN ION CHAMBERS
- Mobility
- Recombination Coefficient
- 8.3 CALCULATION OF EFFICIENCY OF ION COLLECTION - PULSED RADIATION
- Pulsed Radiation
- 8.4 CALCULATION OF THE EFFICIENCY OF ION COLLECTION - CONTINUOUS RADIATION
- Cylindrical and Spherical Chambers
- 8.5 OPERATIONAL AMPLIFIERS
- 8.6 PRACTICAL DEVICES FOR MEASURING RADIATION
- Guarded Construction
- Condenser Chambers
- Townsend Balance
- 8.7 TYPES OF ION CHAMBERS
- 8.8 SOLID STATE DETECTORS
- 8.8.1 Properties and Uses of the Diode Detector
- 8.8.2. Metal Oxide Semiconductor Field Effect Transistors (MOSFETs)
- 8.8.3 Diamond Detectors
- 8.9 THERMOLUMINESCENT DOSIMETRY (TLD)
- 8.9.1 Use of TLDs in neutron dosimetry
- 8.9.2 Optically Stimulated Luminescence
- 8.10 CHEMICAL DOSIMETRY
- 8.10.1 Gel dosimetry in radiation therapy
- 8.11 FILM AS A DOSIMETER
- 8.12 DIRECT MEASUREMENT OF ABSORBED DOSE - THE CALORIMETER
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 9 BASIC RADIOBIOLOGY
- 9.1 INTRODUCTION
- 9.2 INITIAL EVENT-THE PASSAGE OF THE CHARGED PARTICLES
- 9.2.1 Efficiency of Radiation Damage
- 9.2.2 Linear Energy Transfer (LET)
- 9.3 IMMEDIATE RADIOCHEMICAL EFFECTS
- 9.3.1 Production of Solvated Electrons and Radicals
- 9.3.2 Dependence of Radiation Damage on LET
- 9.4 ASSAYS FOR PROLIFERATIVE CAPACITY-SURVIVAL CURVES
- 9.5 MATHEMATICAL ASPECTS OF SURVIVAL CURVES
- 9.5.1 Single-Hit Survival Curve
- 9.5.2 Multi-Target Single-Hit Survival Curve
- 9.5.3 Calculations Using the Survival Curves
- 9.5.4 Other Types of Survival Curves. The Linear Quadratic Model
- 9.6 STATISTICAL NATURE OF RADIATION DAMAGE
- 9.7 RADIATION-INDUCED CELLULAR EFFECTS
- 9.7.1 The Cell Cycle
- 9.7.2 Repairable and Unrepairable Cellular Damage
- 9.7.3 Bystander Effects and Adaptive Response
- 9.8 NORMAL AND TUMOR CELLS-THERAPEUTIC RATIO
- 9.8.1 Tumor Control Probability Models
- Spatial Models of Dose, Tumor Heterogeneity and Response to Treatment
- 9.8.2 NTCP Models: Functional Subunits and Dose-Volume Effects
- The Lyman-Kutcher-Burman Model
- Functional Subunits
- Volume Effects
- The Relative Seriality Model
- Spatial Models of Normal Tissue Complication Probability
- 9.9. RELATIVE BIOLOGICAL EFFECTIVENESS
- 9.9.1 RBE as a Function of LET
- 9.9.2 RBE as a Function of Dose
- 9.9.3 RBE as a Function of Dose per Fraction
- 9.10 THE OXYGEN EFFECT
- 9.10.1 The Oxygen Enhancement Ratio (OER)
- 9.10.2 OER as a Function of LET
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 10 CLINICAL RADIOBIOLOGY
- 10.1 INTRODUCTION
- 10.2 TUMOR GROWTH CHARACTERISTICS
- 10.3 CELL CYCLE AND RADIOSENSITIVITY
- 10.4 THE Rs OF RADIOBIOLOGY
- 10.4.1 Repair
- Survival Curves for Fractionated Treatment
- 10.4.2 Repopulation
- 10.4.3 Redistribution of Cells Along the Cell Cycle
- 10.4.4 Reoxygenation
- 10.4.5 Radiosensitivity
- 10.5 FRACTIONATION IN RADIOTHERAPY AND THE LQ MODEL
- 10.5.1 Incomplete Repair Model
- 10.5.2 The Extended LQ Model for Proliferative Tumors
- 10.5.3 The LQ Model and Reoxygenation
- 10.5.4 The Effect of Fractionation on Early and Late Responding Tissues
- 10.5.5 Choice of Fractionation Based on the Rs of Radiobiology
- A. Altered Fractionation
- B. Fractionation in Specialized Treatments
- 10.6 NORMAL TISSUE REACTIONS
- 10.6.1 The Skin
- 10.6.2 The Hematopoietic System
- 10.6.3 The Gastrointestinal System
- 10.6.4 The Spinal Cord
- 10.7 ISOEFFECT CURVES AND ISOEFFECTIVE DOSES IN RADIOTHERAPY
- 10.7.1 Historical Perspective of Power-law Models
- Nominal Standard Dose
- Time Dose and Fractionation Factors (TDF)
- 10.7.2 Isoeffective Doses in Radiotherapy
- 10.8 THE OXYGEN EFFECT IN CLINICAL SETTINGS
- 10.8.1 High LET Radiation and the Oxygen Effect
- 10.8.2 Radiosensitizers and Anti-Angiogenic Agents
- 10.9 RADIOBIOLOGICAL RATIONALE FOR COMBINED TREATMENT MODALITIES
- 10.9.1 Chemotherapy
- The Role and Action of Chemotherapeutic Agents
- Models in Chemotherapy
- 10.9.2 Hyperthermia
- 10.9.3 Enhancement of TR Through Combined Treatment Modalities
- 10.10 SURVIVAL OF PATIENTS
- Statistical errors
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 11 DIAGNOSTIC RADIOLOGY
- 11.1 INTRODUCTION
- 11.2 THE X-RAY IMAGING CHAIN AS AN INFORMATION PROCESSING SYSTEM
- The imaging chain
- Links of the imaging chain
- 11.2.1 Analyzing an Imaging Chain: Projection Digital Radiography
- X-ray source
- Tube port, beam filters and collimation
- Air gap and diverging beam
- Target tissue ± contrast-enhancing agent
- Scatter rejection grid
- 2D DR detector
- Signal processing and image display
- Visual and cognitive processing
- 11.3 X-RAY PHOTON ABSORPTION & ATTENUATION COEFFICIENTS
- 11.4 DIGITAL FLAT-PANEL X-RAY DETECTORS
- Computed radiography (CR)
- 11.4.1 Active Matrix Arrays as X-ray Image Detectors
- Direct-conversion
- Indirect-conversion
- 11.4.2 Physical Principles of X-ray Flat-panel Detector Materials
- Direct Conversion
- Indirect Conversion
- Structured scintillators
- Unstructured Scintillators
- 11.5 FLAT-PANEL DETECTOR PERFORMANCE CHARACTERISTICS
- Physical Determinants of a Detector's Performance
- Quantum detection efficiency (QDE).
- Dynamic range
- Fill Factor
- Response uniformity
- Sensitivity
- 11.6 DETERMINANTS OF IMAGE QUALITY & THEIR ASSESSMENT
- Determinants of Image Quality
- 11.6.1 Spatial Resolution: The Modulation Transfer Function (MTF)
- The Point, Line, and Edge Spread Functions
- Point Spread Function (PSF)
- Line Spread Function (LSF)
- Edge Spread Function (ESF)
- Mathematical Representations of Spatial Response Functions
- The Modulation Transfer Function
- Spatial frequency: "lp mm-1" vs. "cycles mm-1".
- 11.6.2 Contrast Resolution
- Subject (target) contrast
- Detector contrast
- Displayed (presentation) contrast
- Adjusting for Human Visual Perception
- Just noticeable differences ( JND)
- P-values, standardized display system (SDS).
- DICOM GSDF
- Color imaging
- Low- and high-contrast resolution measurements
- 11.6.3 Sources of Noise in Radiographic Imaging
- Beam-quality noise
- Anatomical noise
- Quantum noise
- Detector resolution noise
- Electronic noise
- Detector structural offset/gain noise
- Summing random noise contributions
- 11.6.4 Signal-to-noise Ratio
- Minimum Patient Dose Burden for a Given Image Noise Level
- 11.6.5 Measuring Noise in the Displayed Image: Contrast-to-noise Ratio and SNR
- Contrast-to-noise Ratio
- Signal-to-noise Ratio
- 11.6.6 Random and Non-random Noise: The Noise Power Spectrum (NPS)
- Structured image noise: simple "square-wave" example
- Aliasing and under-sampling
- Noise power ("Wiener") spectrum
- 11.6.7 Scatter Rejection Grids: Effects on Image Noise
- Scatter rejection grid
- Grid construction
- Scatter Rejection Grid Descriptors
- Grid ratio
- Primary transmission (Tp).
- Bucky factor (BF).
- Focal distance and range
- Grid frequency (fG).
- Contrast improvement factor (K ).
- Image Artifacts from Grids: Aliasing
- 11.7 DETECTIVE QUANTUM EFFICIENCY (DQE)
- Determinants of DQE
- Direct-Conversion Detector
- Indirect-Conversion Detector
- Noise Equivalent Quanta (NEQ ).
- 11.8 EXAMPLE OF PROJECTION RADIOGRAPHY: DIGITAL MAMMOGRAPHY
- Conventional DM.
- Enhancing tumor detection
- Iodine contrast enhancement
- 11.8.1 Single- and Dual-energy Contrast-enhanced Digital Imaging
- Temporal subtraction (TS) CEDM
- Dual-energy subtraction CEDM (CESM)
- 11.8.2 Logarithmic Subtraction of Images
- Subtracting TS CEDM images
- Subtracting dual-energy CEDM images
- Comparison of CEDM Techniques
- CEDM: Example of a Combined Serial-parallel Imaging Chain
- 11.9 EXAMPLE OF PROJECTION RADIOGRAPHY: FLUOROSCOPY & FLUOROGRAPHY
- 11.9.1 Introduction
- 11.9.2 Components of a Fluoroscopic System
- X-rays detection, signal conversion, and amplification
- Conversion stages and their efficiencies
- Nomenclature
- 11.9.3 Performance of a Fluoroscopic System
- XII overall efficiency: the conversion factor
- XII gain factors
- Contrast ratio (CR).
- Spatial resolution
- Temporal resolution
- Noise.
- Image artifacts
- 11.9.4 Digital Fluorography and Digital Subtraction Angiography (DSA)
- Digital subtraction angiography (DSA).
- 11.9.5 Fluoroscopy and Fluorography in Oncology
- Biopsy needle guidance
- Visualization of tumor vasculature
- Correcting for respiratory motion
- 11.10 COMPUTED TOMOGRAPHY (CT)
- 11.10.1 Introduction
- 11.10.2 Physical Principles and Technologies of Single Slice CT
- Coordinate system for the scanning bed: tomographic imaging modalities
- The Basics: First-generation CT Configuration
- CT image representation: "CT numbers".
- Second-generation CT: Multiple Narrow Discrete Beams
- Third-generation CT: Elimination of Translational Motion
- Scanning speed
- Detector stability and response
- Scatter.
- Spatial resolution.
- Dose efficiency.
- Fourth-generation CT Scanners: Source-only Rotation
- Dynamic calibration of detectors
- Spatial resolution
- Ring diameter and number of detectors
- Scatter.
- Multiple-row Detector CT (MDCT)
- 11.10.3 Slip-ring Technology and Helical ("Spiral") CT
- Pitch
- 11.10.4 Multiple-row Detector CT (MDCT)
- Optimization of image quality in MDCT
- 11.10.5 Image Reconstruction Techniques
- Analytical Reconstruction: Filtered Back-projection (FBP)
- Projection function (p).
- Fourier slice theorem
- Summary (without the math).
- Advantages and limitations of FBP
- Convolution of reconstruction kernel with the image data.
- Application to CT Images
- Iterative Reconstruction (IR)
- Algebraic Reconstruction Technique
- General IR Techniques including statistical algorithms
- Reducing radiation dose
- 11.10.6 Cone-beam Computed Tomography (CBCT)
- Current Cone-beam Imaging Technologies
- Image Dose and Optimization
- 11.10.7 Four-dimensional CT (4DCT) Imaging
- Slow CT
- Prospective CT
- Retrospective CT
- Application of 4DCT Datasets
- 11.10.8 Assessing Doses and Upper Dose Limits of CT Scan Protocols
- CT Dose Index, Dose Length Product and Diagnostic Reference Levels
- CT Dose Index (CTDI)
- CTDI100
- CTDIw
- Multiple scan average dose (MSAD).
- Volume CTDI (CTDIvol).
- nCTDIvol
- Dose Length Product (DLP).
- Estimating effective dose from CT dose assessment.
- Diagnostic Reference Levels (DRLs) and Facility Reference Levels (FRLs).
- Dose reduction using iterative reconstruction (IR).
- 11.10.9 Measurements of Image Quality in CT
- CT High-contrast Resolution
- CT Low-contrast Resolution
- Image Optimization to Enhance Visual Perception
- 11.10.10 Artifacts of CT Images and their Minimization
- "Poisson" Noise Artifacts
- Reducing noise artifacts
- Beam Hardening Artifacts
- Reducing beam hardening artifacts
- Scatter Artifacts
- Reducing scattering artifacts
- Metal Artifacts
- Reducing metal artifacts
- Ring, Motion, Cone-beam, Windmill, and Other Artifacts
- 11.11 ULTRASOUND IN MEDICAL IMAGING
- 11.11.1 Introduction
- Biomedical Imaging Capabilities of US
- 11.11.2 Key Physical Concepts in US
- Net pressure (P) and its wavefront
- Phase velocity and group velocity (c and cg).
- Amplitudes (P0 and x0).
- Power (W ).
- Intensity (I ).
- Duty factor (DF )
- Dwell time (td).
- Spatial path length (SPL).
- 11.11.3 US as a Linear Travelling Wave
- Acoustic (Characteristic) Impedance
- Behavior of US at an Interface
- Non-linear Effects
- Reflection, Refraction and Transmission
- 11.11.4 Attenuation of US in Tissues
- Sound intensity and attenuation in dB
- 11.11.5 Generation of US: Single Transducer
- Components of a Single US Transducer Probe
- Piezoelectric element
- Shape of transducer element
- Acoustic matching
- Damping
- Radiative zones of a single disc-like transducer element
- Side lobes
- Grating lobes
- 11.11.6 Generation of US: Transducer Arrays
- Linear and curved sequential arrays
- Phased Arrays
- Enhanced 1D and 2D arrays
- Beam Steering and Focusing
- Minimum Beam Lateral Width (Dx) and Focal Zone (fd )
- 11.11.7 Functions of the Receiver
- Preamplification and ADC
- General RF amplification
- Time gain compensation (TGC).
- Signal compression
- Rectification, demodulation and smoothing
- Data-storage and digital display
- 11.11.8 Types of US Diagnostic Scans
- A-Mode, B-Mode and M-Mode
- A (Amplitude)-mode
- B (Brightness)-mode
- M (Motion)-mode
- Two-dimensional Mode
- Linear sequential array
- Linear phased array
- Beam focusing
- Three-dimensional Mode
- 11.11.9 Basics of Doppler Imaging
- Continuous wave (CW) Doppler
- Pulsed Doppler
- Multiplexed scans
- Doppler flow map (color Doppler)
- Power Doppler
- Harmonic imaging
- Image enhancement using contrast media: molecular US imaging
- 11.11.10 Axial Spatial Resolution
- 11.11.11 Lateral and Elevational Spatial Resolutions
- Lateral resolution
- Elevational resolution
- 11.11.12 Temporal Resolution
- 11.11.13 Biological Effects and Safety: Choice of Beam Parameters
- Thermal Effects: "Thermal Index" (TI)
- Thermal index
- Cavitation Effects: "Mechanical Index" (MI)
- Mechanical index
- Model for beam attenuation
- Other mechanical effects: radiation force and acoustic streaming
- Choice of Beam Central Frequency
- Diagnostic.
- Therapeutic.
- 11.11.14 Applications of US Imaging to Cancer Diagnosis and Management
- 11.11.15 Artifacts in US Imaging
- Beam behavior physical assumptions
- Types of US Image Artifacts
- Beam physical characteristics
- mass would be assigned erroneously.Reflection, refraction and multiple paths
- Beam attenuation anomalies.
- Beam velocity anomalies
- 11.12 MAGNETIC RESONANCE IMAGING (MRI)
- 11.12.1 Introduction: Historical Development of NMR and MRI
- 11.12.2 Magnetic Fields in Materials
- Nuclear Paramagnetism
- Volume Bulk Magnetization
- When does N differ from Nw?
- Magnetic Susceptibility: Paramagnetism and Diamagnetism
- 11.12.3 The Bloch Equations
- 11.12.4 Free Precession and Larmor Frequency
- 11.12.5 Relaxation of the Magnetic Moment
- 11.12.6 RF Excitation of the Magnetic Moment
- Rotating Reference Frame and Effective Magnetic Field
- Free precession as seen in the rotating frame
- Equation of motion for magnetization in the rotating frame
- 11.12.7 RF Excitation and Magnetization Relaxation
- Transverse Projection of the Magnetization: The "Spin Flip Angle"
- The "90°" spin flip pulse
- Why does M rotate and the "spin flip angle" achange?
- Switching off the RF.
- Extrinsic inhomogeneities in the static magnetic field: apparent relaxation time T2* .
- 11.12.8 T1, T2 & T*2 Relaxation Mechanisms and Proton Density
- Molecular motion correlation times
- Chemical Shift and J-coupling
- Chemical shift of hydrogen nuclei (d).
- J-coupling (NJA-B).
- T1 Relaxation Mechanisms
- Regime A.
- Regime B.
- Regime C.
- T2 and T2* Relaxation Mechanisms
- Proton Density
- 11.12.9 Optimizing MRI Image Contrast: MRI Sequences
- The "180° Pulse" and Subsequent Mz Recovery: Mechanisms and Outcomes
- 11.12.10 SE and Fast SE Sequences: Highlighting T2 Effects
- Readout signal strength
- Fast ("Turbo") Spin Echo Sequences
- "Fat signal" expression in T2-weighted conventional SE and FSE images
- 11.12.11 IR Sequence: Highlighting T1 Effects
- Readout signal strength
- 11.12.12 GRE Sequence: Highlighting T2* and Acquisition Speed
- Characteristics of the GRE Sequence
- Highlighting T2* mechanisms: shorter TEs
- Spin flip (or "spin tip") angle a &90°: shorter TR
- 11.12.13 Contrast-enhancing Variables of MRI Sequences: Summary
- Choice of pulse sequence
- Repetition time (TR).
- Time of echo (TE).
- Time of Inversion (TI).
- The spin flip angle (a) and partial saturation.
- Steady-state Partial Saturation
- Flow-related (inflow) enhancement.
- 11.12.14 Spatial Localization of MR Signals Readout
- Transaxial Slice Selection: Gz-Gradient
- Voxel Selection Within a Slice: Phase and Frequency Encoding
- Phase-encoding of spins along the y-axis
- Frequency-encoding of spins along the x-axis
- MR signals readout
- Representation in k-space
- Repeated phase encoding steps.
- Meaning of k-space regions
- Reconstruction of MR image
- 11.12.15 Symbolic Representations of Pulse Sequences: SE, GRE and EP
- Pulse sequence notation
- Echo planar (EP) imaging
- Single-shot vs. multi-shot EP acquisitions: echo train length (ETL)
- 11.12.16 Artifacts of MR Images and Their Minimization
- Artifacts caused by physiological processes
- Artifacts arising from the underlying physics
- Artifacts arising from MRI software or hardware
- 11.13 IMAGE REGISTRATION
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 12 DIAGNOSTIC NUCLEAR MEDICINE
- 12.1 INTRODUCTION
- 12.1.1 Nuclear Medicine, Molecular Imaging & Molecular Medicine
- 12.2 THE GEIGER-MÜLLER COUNTER
- Recombination region
- Ionization chamber region.
- Proportional counter region
- Limited proportional region
- Geiger-Mu¨ller region
- Continuous discharge region
- Gamma Counting
- Beta & Alpha Counting
- 12.3 THE SCINTILLATION DETECTOR
- Contributors to energy resolution
- Intrinsic energy resolution
- Effect of energy resolution on displayed spectra
- Scintillation counter vs. Geiger counter
- 12.4 THE LIQUID SCINTILLATION COUNTER
- Basic electronic circuit
- 12.5 THE SEMICONDUCTOR DETECTOR
- 12.6 STATISTICS OF RADIONUCLIDE DISINTEGRATION COUNTING
- Poisson probability distribution
- Standard deviation and probable error
- Background counts
- 12.7 DEAD TIME & LOSS OF COUNTS
- 12.8 SAMPLE COUNTING: UPTAKE & VOLUME STUDIES
- 12.8.1 Example: Measurement of Thyroid Iodine Uptake
- 12.8.2 Example: Determination of Plasma Volume Using a Well Counter
- 12.9 IMAGING USING RADIONUCLIDES
- 12.9.1 Historical Development
- Nuclear Medicine Legacy: Development of Bone Densitometry
- 12.9.2 The Scintillation ("Gamma") Camera
- The patient as a macroscopic, diffuse radiation source
- Collimator: photon scatter discrimination
- Field of view (FOV).
- Detector crystal and light guide ("light pipe").
- Photomultiplier-tube (PMT) array
- X-ray or g-ray detection
- Photon energy discrimination
- Compensation for scattering events
- Spatial encoding
- Assembling and processing the image
- Anatomic (Structural) vs. Functional (Pharmacokinetic) Imaging
- 12.9.3 Scintillation Camera Physical Performance Characteristics
- Spatial Resolution
- Collimator spatial resolution
- Intrinsic spatial resolution
- System spatial resolution and line spread function (LSF).
- Multiple-windows spatial registration
- Efficiency
- Collimator Geometric Efficiency
- Intrinsic crystal efficiency
- System efficiency
- Contributors to system efficiency
- Types of Collimators
- Field Uniformity
- Random errors in imaging chain
- Systematic errors in imaging chain
- 12.9.4 Quality Assurance of Scintillation Cameras
- QC Performance Tests Using the NEMA Protocol
- 12.9.5 Single Photon Emission Computed Tomography (SPECT)
- 12.9.5.1 SPECT Image Data Collection
- Multi-headed Cameras
- SPECT Collimators
- 12.9.5.2 Image Reconstruction in SPECT
- Filtered Back-projection Applied to Emission Tomography
- Iterative Reconstruction Applied to Emission Tomography
- 12.9.5.3 Filtration in SPECT Image Reconstruction
- Image filtration
- Types of Filters Used in SPECT FBP Reconstructions
- Reduction in star artifact
- High-frequency noise suppression
- Filtered back-projection: window filter
- Types of Filters Used in SPECT Iterative Reconstructions
- OSEM vs. FBP
- Molecular SPECT
- Signal Enhancement for Restoration of Lost Information
- 12.9.5.4 Photon Attenuation in SPECT Image Reconstruction
- Chang attenuation correction
- Concomitant radioisotopic transmission data acquisition
- X-ray transmission computed tomography data acquisition
- 12.9.5.5 Quality Assurance of SPECT Cameras
- 12.9.5.6 Studies with Diagnostic SPECT Radiopharmaceuticals
- 12.9.6 Positron Emission Tomography (PET)
- 12.9.6.1 Scientific & Technical Discoveries Leading to PET
- 12.9.6.2 Coincidence-detection of Annihilation Photons
- Coincidence Detection System
- 12.9.6.3 Types of Recorded Events
- True and prompt coincidences
- Scattered coincidences
- Random coincidences
- Multiple coincidences
- Advanced PET: false coincidences derived from prompt gammas
- 12.9.6.4 PET Detector Materials
- Key Properties of Scintillators
- Quantum detection efficiency
- Energy resolution
- Photoelectron yield
- Photon yield
- Decay time
- 12.9.6.5 Characteristics & Hierarchical Assembly of PET Detector Elements
- Typical Whole-body PET/CT System Incorporating TOF
- Time of flight (TOF).
- Comparison with preclinical PET/CT systems: phoswich detectors
- 12.9.6.6 Acquisition of Coincidence Data
- Defining the orientation of an LOR
- Indexation of an LOR
- Modes of events recording
- 2D vs. 3D acquisitions
- Angular mashing and undersampling
- Data Assembly & Representation: The Sinogram
- The sinogram
- "Squaring the circle".
- 12.9.6.7 Data Corrections in PET
- Normalization of Detectors & Their Circuitry
- Measurement of normalization coefficients
- Correction for Attenuation
- Modeling and calculation
- Measurement using transmission from isotopic source
- Measurement using transmission CT scan
- Correction for Scattering
- Analytical methods
- Dual-energy methods
- Model-based methods
- Correction for Random Coincidences
- Prompt timing window method
- Delayed timing window method
- Correction for Dead Time in PET
- Nonparalyzable detection system
- Paralyzable detection system and pulse pileup
- Contributors to dead time in PET detectors
- Measurement of dead time in PET
- Noise-equivalent Counts & Scatter Fraction
- Noise-equivalent counts (NEC) and count rate (NECR)
- Scatter Fraction (SF).
- 12.9.6.8 PET Image Quality
- Spatial Resolution of PET
- Positron range
- Noncollinearity of annihilation photons
- Detector element size
- Detector element construction: depth encoding.
- Geometric layout of detectors and detector blocks
- Photodetector PMT array: numbers and packing of PMTs.
- Combining these uncertainties
- Sensitivity of PET
- Coincidence detection efficiency
- Detection system geometrical efficiency
- Detector active fraction
- System sensitivity
- 12.9.6.9 Emerging Technologies for Improving PET Performance & Scope
- Silicon Photomultipliers (SiPM) in PET
- Avalanche photodiodes
- "Geiger-mode" APDs and silicon photomultipliers
- Total-Body PET Imaging
- 12.9.6.10 Artifacts of PET Images & Their Minimization
- Metallic implants
- Contrast media
- Truncation errors
- 12.9.6.11 Clinical Applications of PET Radiopharmaceuticals
- 12.9.6.12 Interpretation & Quantification of PET Images
- Semi-quantitative PET Imaging: Standardized Uptake Value (SUV)
- Filtration in PET image reconstruction
- Combining Radioactive Modalities: Theranostics
- Theranostic cancer management
- Theranostic partnership: MRT plus PET and SPECT in prostate cancer treatment
- 12.10 PHYSICAL, BIOLOGICAL & EFFECTIVE HALF LIVES
- Reservations Concerning the Biological Half-Life
- 12.11 KINETIC MODELING TECHNIQUES FOR NUCLEAR MEDICINE
- Biological modeling
- Noncompartmental methods
- Distributed modeling
- Kinetic (or "dynamic") compartmental modeling
- 12.11.1 Constructing a Compartmental Kinetic Model
- 12.11.2 Modeling Receptor-Ligand Data in PET & SPECT Imaging
- Radioligand In Vitro Assay Model
- Dissociation Constant
- Binding potential (BP).
- Free receptor density (Bmax).
- In Vivo Model for PET Brain Receptor Binding Studies
- 12.12 OPTIMIZING DIAGNOSTIC DOSES TO NUCLEAR MEDICINE PATIENTS
- Diagnostic Reference Levels in Nuclear Medicine
- Applying ALARA-like Radiation Protection Principles to the Patient
- Reducing Doses from Diagnostic Administrations
- Dose-reduction example: 67Ga vs. 68Ga imaging for infection
- Dose-reduction example: 111In vs. 68Ga imaging for neuroendocrine tumors
- 12.13 ABSORBED DOSE ARISING FROM A RADIONUCLIDE IN THERAPY
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 13 CHARACTERISTICS OF RADIOTHERAPY PHOTON BEAMS
- 13.1 COMPONENTS OF THE INCIDENT BEAM
- 13.2 DETERMINATION OF BEAM CHARACTERISTICS
- 13.2.1 Monte Carlo Modeling
- 13.2.2 Source Models
- 13.3 KILOVOLTAGE BEAMS
- 13.3.1 Accelerated Electrons
- 13.3.2 Target and Filters
- 13.3.3 Collimation
- 13.3.4 Contamination
- 13.4 PHOTON BEAMS FROM ELECTRON ACCELERATORS
- 13.4.1 Initial Electron Beam
- 13.4.2 Target
- 13.4.3 Flattening Filter
- Flattening Filter Free Beams
- 13.4.4 Collimation
- Custom Field Definition
- Impact of Collimation on Accelerator Output
- Occlusion of Source by Collimation
- 13.4.5 Monitor Chamber
- 13.4.6 Modulated Fields
- Modulation with a Multileaf Collimator
- 13.4.7 Intervening Components
- Intervening Materials
- Intervening Magnetic Fields
- 13.4.8 Leakage
- 13.4.9 Neutron Production and Activation
- 13.4.10 Final Beam
- 13.4.11 Source Models for Photon Beams
- 13.5 COBALT-60 BEAMS
- 13.5.1 Source and Collimation
- 13.5.2 Leakage
- 13.5.3 Beam Modulation
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 14 THE INTERACTION OF PHOTON BEAMS WITH A SCATTERING MEDIUM
- 14.1 QUANTIFYING DOSE IN A SCATTERING MEDIUM
- 14.1.1 Static Fields
- 14.1.2 Dynamic Fields
- 14.1.3 Comparing Dose Distributions
- 14.2 COMPONENTS OF DOSE IN A SCATTERING MEDIUM
- 14.3 PATTERNS OF DOSE IN A SCATTERING MEDIUM
- 14.3.1 Dose Build-Up
- 14.3.2 Surface Dose
- 14.3.3 Beyond dm
- 14.3.4 Lateral Electronic Equilibrium
- 14.3.5 Off-Axis Dose Distribution
- Side Scatter
- 14.3.6 Narrow Beams
- 14.3.7 Contour Shape
- 14.3.8 Dose at Exit Surface
- 14.3.9 Inhomogeneities
- 14.3.10 Energy Absorption in Biological Material
- Structure of Bone
- Dose to Bone
- Dose Near a Bone Interface
- Air Cavities
- Lung
- 14.3.11 Inadvertent Dose in the Medium
- Sources and Impacts
- Impact of Collimation
- 14.3.12 Modulation
- Transmission Modulation
- Superposition Modulation
- 14.3.13 Impact of Magnetic Fields
- 14.4 EMPIRICAL DESCRIPTIONS OF PHOTON BEAM DOSE DISTRIBUTIONS
- 14.4.1 Functions Used to Describe Central Axis Dose
- Relationship Between the Functions
- 14.4.2 Tissue-Air Ratio
- Effect of Distance from the Source on the Tissue-Air Ratio
- Variation of Tissue-Air Ratio with Field Size and Depth
- Derivation of Tissue-Air Ratios
- 14.4.3 Backscatter Factor and Peak Scatter Factor
- Backscatter/Peak Scatter Factor and Beam Quality
- 14.4.4 Percentage Depth Dose
- Dependence of PDD on Source to Surface Distance
- Dependence of Depth Dose on Beam Modifiers
- 14.4.5 Tissue-Phantom Ratio and Tissue Maximum Ratio
- 14.4.6 Off-axis Ratio
- 14.4.7 Scatter-Air Ratio and Scatter Maximum Ratio
- 14.4.8 Equivalent Squares and Circles for Rectangular and Irregular Fields
- 14.4.9 Estimation of Parameters for Irregular Fields
- 14.4.10 Central Axis Depth Dose and Beam Quality
- 14.5 ABSOLUTE DOSE - DOSE OUTPUT
- 14.5.1 Variations with Field Size - Component Scatter Factors
- Total Scatter Factors
- Collimator Scatter Factors
- Phantom Scatter Factors
- 14.5.2 Asymmetric Fields
- 14.5.3 Treatment Accessories
- 14.5.4 Impact of Flattening Filter
- 14.5.5 Narrow Beams
- 14.5.6 Modulated and Composite Beams
- 14.6 TABULAR DATA IN THE APPENDIX
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 15 EXTERNAL PHOTON BEAM DOSE CALCULATION
- 15.1 INTRODUCTION
- 15.2 ABSOLUTE AND RELATIVE DOSE
- 15.2.1 Device Output - Absorbed Dose Determination
- 15.2.2 Beam Output Determination
- 15.3 DOSE CALCULATION REQUIREMENTS
- 15.3.1 Uncertainties, Deviations, Errors, and Tolerances
- 15.3.2 Dose Calculation Accuracy
- Absolute Dose
- Relative Dose
- Calculation Rigor
- 15.3.3 Spatial Resolution and Calculation Speed
- 15.3.4 Required Information
- 15.3.5 Independent Dose Calculation
- 15.4 DEFINITION OF THE GEOMETRY AND MEDIA
- 15.4.1 Coordinate Systems
- Imaging/Simulation
- Treatment Plan
- Treatment
- 15.4.2 Definition of Media
- Determination of Electron Density from CT - Theoretical
- Determination of Electron Density from CT - Experimental
- Determination of Media Composition
- Determination of Media from Other Imaging Modalities
- Estimation of Electron Scattering and Stopping Power from CT
- 15.4.3 Medium for Calculation and Specification of Dose
- 15.4.4 Geometry and Calculation Grids
- 15.4.5 Depth and Path-Length Scaling in Heterogeneous Media
- 15.4.6 Medium Artifacts
- 15.5 CLASSIFICATION OF ALGORITHMS
- 15.6 ALGORITHMS BASED ON EMPIRICAL DESCRIPTIONS OF DOSE DISTRIBUTIONS
- 15.6.1 Basic Point Dose and MU Calculations
- Calculation Based on TPR
- Calculation Based on PDD
- Kilovoltage Therapy Output
- 15.6.2 Combining Primary and Scatter
- Primary Dose in a Phantom
- Addition of Scatter
- 15.6.3 Corrections for Inhomogeneities
- Alteration of Isodose Curves by Contour Shape
- Dose Corrections for Tissue Inhomogeneities
- 15.6.4 Corrections in Non-uniform Fields
- 15.7 ALGORITHMS BASED ON DEPOSITION KERNELS
- 15.7.1 Dose Deposition Kernels
- 15.7.2 Calculation with Pencil Beam Kernels
- Correction for Inhomogeneities
- Correction for Energy and Directional Variations
- 15.7.3 Calculation with Point Kernels
- Correction of Kernel for Inhomogeneities
- Correction of Kernel for Energy Variations
- Correction of Kernel for Directional Variations
- Collapsed Cone Convolution
- 15.8 ALGORITHMS BASED ON EXPLICIT PARTICLE TRANSPORT
- 15.8.1 Stochastic Methods
- Monte Carlo Requirements
- Geometry, Beams and Environment
- Medium
- Dose and Uncertainty
- 15.8.2 Deterministic Methods
- 15.9 COMPARISON OF PHOTON DOSE CALCULATION ALGORITHMS
- 15.9.1 Differences in Dose Calculation
- 15.9.2 Clinical Impact of Differences in Dose Calculation
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 16 PHOTON BEAM TREATMENT: DOSE PRESCRIPTION AND REPORTING
- 16.1 THE RADIOTHERAPY TREATMENT CYCLE
- 16.2 UNCERTAINTIES IN TREATMENT PLANNING AND DELIVERY
- 16.2.1 Dosimetry
- 16.2.2 Geometry
- Equipment-Related Uncertainties
- Patient and Organ Positioning
- 16.3 DEFINITION OF VOLUMES
- 16.3.1 Definition of Anatomical Volumes
- 16.3.2 International Volume Definitions - Margins
- Target Volume
- Establishing the Setup Margin
- OAR Volume
- Treated Volume
- 16.3.3 Definition of Functional Volumes
- Continuous Functional Distributions
- Discrete Functional Volumes
- 16.4 DOSE SPECIFICATION AND EVALUATION
- 16.4.1 Dose Prescribing and Dose Reporting-Dose-Volume
- Reference Points
- Dose-Volume Histograms
- Dose-Volume Parameters
- 16.4.2 Dose Evaluation-Physical Metrics
- Evaluation Using Dose-Volume Parameters
- Other Physical Metrics
- 16.4.3 Dose Evaluation-Radiobiological Metrics
- TCP, NTCP, and UTCP
- Fractionation Correction
- Equivalent Uniform Dose (EUD)
- 16.4.4 Dose Prescription
- Physical Prescription
- Radiobiological Prescription
- 16.4.5 Spatial Dose Assessment
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 17 PHOTON BEAM TREATMENT: PLANNING AND DELIVERY
- 17.1 TREATMENT BEAM DEFINITION
- 17.1.1 Pairs of Beams
- Opposing Pairs of Beams
- Combinations of Opposing Pairs
- 17.1.2 Wedged Fields
- 17.1.3 Multiple Coplanar Beams with Beam Shaping
- 17.1.4 Coplanar Rotation and Arc Therapy-Static Fields
- 17.1.5 Beam Modulation
- 17.1.6 Rotation and Arc Therapy-Modulated Fields
- 17.1.7 Noncoplanar Delivery
- 17.1.8 Stereotactic Treatments
- Stereotactic Treatments with Multiple Static Sources
- Stereotactic Treatments with C-arm Accelerators
- Stereotactic Treatments with Robotically Mounted Accelerators
- Comparison of Stereotactic Techniques
- 17.1.9 Matching Fields
- 17.1.10 Whole Body Irradiation
- Conventional
- Targeted
- 17.2 TREATMENT PLAN OPTIMIZATION
- 17.2.1 Treatment Planning as an Optimization Problem
- 17.2.2 Objectives, Constraints, and Search Space
- Cost Functions
- Constraints
- Search Space
- Constraints as Objectives
- Radiobiological Objectives
- 17.2.3 Solutions
- Solution Acceptability and Sources of Information
- Convexity
- Degeneracy
- Robustness
- 17.2.4 Optimization Algorithm
- Starting Point
- Search Algorithm
- Deterministic
- Stochastic
- Finishing Point
- Bixel-Based vs. Direct Aperture Optimization
- 17.2.5 Multi-criteria Optimization
- 17.3 TREATMENT VERIFICATION, CORRECTION, AND ADAPTATION
- 17.3.1 Geometric Verification
- kV vs. MV X-ray Imaging
- In-Room Imaging Options for IGRT
- Digitally Reconstructed Radiographs for Verification
- Positioning and Immobilization
- Target Localization
- 17.3.2 Geometric Correction
- Setup Correction
- Motion Management
- 17.3.3 Dosimetric Verification
- Imaging Panels as Dosimeters
- Pre-treatment Verification
- Direct Patient In Vivo Dosimetry
- In Vivo Dosimetry Using Imaging Panels
- Dose Recalculation and Accumulation
- Dosimetric Audit
- 17.3.4 Treatment Adaptation
- Manual Adaptation
- Adaptive Re-planning
- Real-time Adaptation to Motion
- 17.3.5 Functional Guidance, Adaptation, and Assessment
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 18 EXTERNAL ELECTRON BEAMS
- 18.1 ELECTRON BEAM CHARACTERISTICS
- 18.1.1 Initial Electron Beam
- 18.1.2 Scattering Foils
- 18.1.3 Collimation
- 18.1.4 Modulated Fields
- 18.1.5 Intervening Components
- 18.1.6 Leakage
- 18.1.7 Neutron Production and Activation
- 18.1.8 Final Beam
- 18.1.9 Source Models for Electron Beams
- 18.2 ABSORBED DOSE IN A SCATTERING MEDIUM
- 18.2.1 Electron Pencil Beams
- 18.2.2 Surface Dose
- 18.2.3 Dose Build-up
- 18.2.4 Beyond dm
- 18.2.5 Relationship Between Beam Quality and Central Axis Dose Distribution
- 18.2.6 Contamination/Bremsstrahlung Tail
- 18.2.7 Off-Axis Distribution
- 18.2.8 Oblique Incidence
- 18.2.9 Medium Inhomogeneities
- 18.2.10 Internal Shielding
- 18.2.11 Equivalent Fields
- 18.2.12 Output Variations
- 18.3 ELECTRON BEAM DOSE CALCULATION
- 18.3.1 Calculation of Output
- 18.3.2 Pencil Beam Algorithm
- Determination of Spatial Dependence
- Impact of Beam Angular Variations
- Conversion to Dose
- Dose Distribution for Arbitrary Field Shape
- Incorporating Bremsstrahlung
- More Rigorous Pencil Beam Methods
- 18.3.3 Monte Carlo
- 18.3.4 Comparison of Pencil Beam Algorithms with Monte Carlo
- 18.4 ELECTRON BEAM TREATMENT PLANNING AND DELIVERY
- 18.4.1 Dose Specification
- 18.4.2 Treatment Beam Placement
- 18.4.3 Shielding
- 18.4.4 Bolus Compensation
- 18.4.5 Electron Field Matching
- 18.4.6 Electron-Photon Field Matching
- 18.4.7 Total-Skin Electron Therapy
- Fixed-Fields Technique
- Rotational Technique
- 18.4.8 Electrons vs. Photons for Superficial Treatments
- 18.5 TABULAR DATA IN THE APPENDIX
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 19 RADIOTHERAPY WITH NEUTRONS, PROTONS AND HEAVY IONS
- 19.1 RATIONALE FOR CONSIDERING HIGHER LET PARTICLES
- 19.1.1 Neutrons
- 19.1.2 Protons
- 19.1.3 Heavy Ions
- 19.2 NEUTRON RADIOTHERAPY
- 19.2.1 Early Studies with Neutrons
- 19.2.2 Neutron Generating Equipment, Dosimetry and Treatment Planning
- Deuterium Tritium (D-T) Generators
- Cyclotrons
- Collimation of Fast Neutrons
- 19.2.3 Current Fast Neutron Therapy Programmes
- 19.2.4 Boron Neutron Capture Therapy
- Therapeutic Basis for BNCT
- Neutron Sources
- Suitable Boronated Compounds
- Treatment Planning
- Clinical Results
- 19.3 PROTON RADIOTHERAPY
- 19.3.1 Clinical Indications for Charged Particle Therapy
- 19.3.2 Proton Treatment Radiobiology and Fractionation
- 19.3.3 Proton Beam Facilities
- 19.3.4 Scanning Spot Beams versus Passive Scattering
- 19.3.5 Treatment Planning
- 19.4 HEAVY PARTICLE BEAMS
- 19.4.1 Carbon Ions
- 19.4.2 Other Particles and Heavy Ions
- 19.5 THE FUTURE OF PARTICLE THERAPY
- PROBLEMS
- REFERENCES
- Chapter 20 BRACHYTHERAPY
- 20.1 BRACHYTHERAPY-INTRODUCTION
- 20.1.1 Historical Perspective: Radium and Radon
- 20.1.2 Definitions and Classifications
- 20.2 SOURCES USED IN BRACHYTHERAPY AND THEIR PHYSICAL CHARACTERISTICS
- 20.2.1 Gamma-Emitting Radioisotopes Used in Brachytherapy
- Cesium-137
- Cobalt-60
- Gold-198
- Iridium-192
- Iodine-125
- Palladium-103
- 20.2.2 Beta-Emitting Radioisotopes Used in Brachytherapy
- Ruthenium-106
- Strontium-90
- Phosphorus-32
- 20.2.3 Neutron-Emitting Radioisotopes Used in Brachytherapy
- Californium-252
- 20.3 DOSE PRESCRIPTION AND CALCULATIONS
- 20.3.1 Introduction: Historical Perspective
- 20.3.2 The Stockholm and Paris Systems
- 20.3.3 The Manchester System
- 20.3.4 Current Dosimetric Systems
- 20.3.4.1 TG-43 Calculation
- 20.3.4.2 Model-based Calculation
- 20.3.5 Current Dosimetric Systems
- 20.3.5.1 Intracavitary Brachytherapy
- 20.3.5.2 Interstitial Brachytherapy
- 20.3.5.3 Superficial Brachytherapy (Surface Plaques and Molds)
- Eye plaques
- Surface molds
- 20.3.5.4 Intravascular Brachytherapy
- Temporary Intravascular Brachytherapy
- Permanent Intravascular Brachytherapy
- 20.4 MINIATURE X-RAY THERAPY SOURCES
- 20.4.1 Introduction
- 20.4.2 Xoft® Source
- 20.4.3 Intrabeam®
- 20.5 QUALITY ASSURANCE AND RADIATION SAFETY WITH SEALED SOURCES
- 20.5.1 Quality Assurance and Radiation Safety in HDR Brachytherapy
- 20.5.2 Quality Assurance and Radiation Safety in LDRBrachytherapy with Interstitial Implants
- 20.5.3 Quality Assurance and Radiation Safety in Brachytherapy Using Eye Plaques
- 20.5.4 Quality Assurance and Radiation Safety in Intravascular Brachytherapy
- 20.6 UNSEALED SOURCE RADIOTHERAPY-HISTORICAL PERSPECTIVEAND GENERAL CONSIDERATIONS
- 20.6.1 Unsealed Source Radiotherapy-Historical Perspective
- 20.6.2 Classification of Radioisotopes
- 20.6.3 Clinically Used Unsealed Radioisotopes
- 20.7 UNSEALED SOURCES USED FOR THERAPEUTIC PURPOSES
- 20.7.1 Iodine-131 (Radioiodine)
- 20.7.2 Phosphorus-32
- 20.7.3 Lutetium-177, Yttrium-90, and Indium-111
- 20.8 UNSEALED SOURCES USED FOR PALLIATIVE PURPOSES
- 20.8.1 Strontium-89
- 20.8.2 Samarium-153
- 20.9 QUALITY ASSURANCE FOR UNSEALED SOURCES AND RADIATION SAFETY
- 20.10 ADVANTAGES OF BRACHYTHERAPY OVER EXTERNAL BEAM RADIOTHERAPY
- PROBLEMS
- REFERENCES
- Chapter 21 MOLECULAR RADIOTHERAPY
- 21.1 INTRODUCTION
- Learning from external beam irradiations
- Unsealed isotopes therapies: coming of age?
- 21.2 OPPORTUNITIES AND CHALLENGES FOR MOLECULAR RADIOTHERAPY
- Thyroid cancer
- Hematological malignancies
- Metastatic neuroendocrine tumors (NETs).
- Metastatic, castration-resistant prostate cancer
- Pediatric malignancies
- Alpha-therapies for a range of malignancies
- Beyond palliation? Bone-seeking radionuclidic therapy that extends life
- 21.3 HYBRID EXTERNAL BEAM AND MOLECULAR RADIATION THERAPIES
- 21.4 LQ MODEL APPLIED TO MOLECULAR RADIOTHERAPY
- EBRT mechanisms vs. MRT mechanisms
- 21.4.1 BED and Lea-Catcheside Factor
- Limiting values of G
- G and BED expressions for MRT
- Variations in parameters a, b and TP
- 21.5 APPLICATION OF BED TO PLANNING AND IMPLEMENTATION OF HYBRID THERAPIES
- Limitations of the method
- 21.5.1 Example of Hybrid Therapy
- 21.6 INTERNAL RADIOPHARMACEUTICAL DOSE ASSESSMENT
- 21.6.1 The Absorbed Dose in EBRT and MRT
- 21.6.2 Different Approaches to Absorbed Dose Assessment
- Historical development
- 21.6.3 Simplified Development of MIRD Formalism
- Calculating the Mean Absorbed Dose in MIRD: Time-integrated Activity Ã
- Calculating the Mean Absorbed Dose in MIRD: The S-Factor
- Combining à and S-Factor
- 21.6.4 General Time-dependent Formulation of MIRD
- 21.6.5 Time-independent Formulation of MIRD
- Self-irradiation of a Target
- Conversion to Equivalent Dose: Limitations of Concept
- 21.7 THE "RADAR" FORMULATION
- Calculation of the Time-integrated Activity
- Calculation of the Dose Factor: Use of Computational Phantoms
- 21.8 THE EFFECTIVE DOSE: LONG-TERM STOCHASTIC RISK PREDICTION
- 21.8.1 Efficacy and Limitations of the Effective Dose
- Comparison between dose coefficients
- 21.8.2 Dose Assessments of Common DiagnosticNuclear Medicine Investigations
- Limitations of the "Effective Dose" Concept in Nuclear Medicine
- 21.9 RELATIVE BIOLOGICAL EFFECTIVENESS: STOCHASTICAND DETERMINISTIC PREDICTIONS
- Linear energy transfer
- Variations in LET for particles.
- 21.9.1 Consideration of RBEm for Deterministic Effects
- Determinants of RBEm
- RBE-weighted Absorbed Dose
- 21.10 OTHER DOSE-RELATED QUANTITIES FOR PREDICTINGDETERMINISTIC EFFECTS
- 21.10.1 Biologically Effective Dose
- 21.10.2 Dose Volume Histogram (DVH) and BED Volume Histogram (BVH)
- 21.10.3 Equivalent Uniform Dose (EUD)
- 21.10.4 Isoeffective Dose (DIsoE)
- 21.11 NORMAL TISSUE COMPLICATION PROBABILITY (NTCP)CURVE AND APPLICATIONS
- 21.11.1 Predicting MRT Renal Toxicity Using NTCP and BED
- Aligning Outcomes of Different Treatments Using NTCP and BED
- SUMMARY
- PROBLEMS
- REFERENCES
- Chapter 22 RADIATION PROTECTION
- 22.1 INTRODUCTION
- 22.2 RADIATION QUANTITIES AND UNITS
- 22.2.1 Absorbed Dose. Organ Dose
- 22.2.2 Equivalent Dose and Radiation Weighting Factors
- 22.2.3 Effective Dose and Tissue Weighting Factors
- 22.3 SOURCES OF RADIATION
- 22.3.1 Background Radiation
- 22.3.2 Man-Made Radiation
- 22.4 EXPOSURE TO IONIZING RADIATION
- 22.4.1 Deterministic and Stochastic Effects
- 22.4.2 Dose Limits
- Dose to the Embryo and Foetus
- Dose to Patients with Implanted Electro-mechanical Devices
- 22.4.3 Exposure to Personnel from Diagnostic and Interventional Radiology
- 22.4.4 Risk of Second Cancer after Radiotherapy for Primary Cancer
- 22.4.5 Radiation Hormesis
- 22.5 RADIATION SHIELDING
- 22.5.1 Radiation Sources
- 22.5.2 Shielding Materials
- 22.5.3 Factors Affecting Shielding Calculations
- Workload
- Use Factor (U )
- Direction Factor (f )
- Occupancy Factor (T)
- Inverse Square Law
- Regulations
- 22.5.4 Shielding Calculations for External Beam Facilities
- Primary Barriers
- Secondary Barriers
- Mazes
- Shielded Doors and Ducts
- Sky Shine
- Photo-Nuclear Activation
- Specialist Facilities
- 22.5.5 Shielding Calculations for Brachytherapy Techniques
- High-Dose Rate Brachytherapy
- After-loading Low-Dose Rate Brachytherapy
- Other Techniques
- 22.5.6 Shielding Calculations for Diagnostic Radiology Facilities
- 22.5.7 Detailed Report Summarizing Calculations Performed
- Provision of Room Design (including Plans and Elevation)
- 22.6 RADIATION SHIELDING EVALUATION
- 22.6.1 Inspection Before and During Bunker Construction
- 22.6.2 Radiation Warning Lights, Interlocks and Restrictions on the Access for Staff, Patients and the General Public
- 22.6.3 Radiation Survey and Report
- 22.7 PERSONNEL MONITORING
- 22.7.1 Personal Radiation Dosimeters - Types and Characteristics
- 22.7.2 Operational Quantities for Personnel Dosimetry
- PROBLEMS
- REFERENCES
- APPENDICES
- Appendix A BASIC DATA
- Appendix B PHOTON RADIATION THERAPY DATA
- Appendix C ELECTRON RADIATION THERAPY DATA
- INDEX
System requirements
File format: PDF
Copy-Protection: Adobe-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Install the free reader Adobe Digital Editions prior to download (see eBook Help).
- Tablet/smartphone (Android; iOS): Install the free app Adobe Digital Editions or the app PocketBook before downloading (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (only limited: Kindle).
The file format PDF always displays a book page identically on any hardware. This makes PDF suitable for complex layouts such as those used in textbooks and reference books (images, tables, columns, footnotes). Unfortunately, on the small screens of e-readers or smartphones, PDFs are rather annoying, requiring too much scrolling.
This eBook uses Adobe-DRM, a „hard” copy protection. If the necessary requirements are not met, unfortunately you will not be able to open the eBook. You will therefore need to prepare your reading hardware before downloading.
Please note: We strongly recommend that you authorise using your personal Adobe ID after installation of any reading software.
For more information, see our eBook Help page.